Fundz

SystImmune

Redmond, Washington, United States · Biopharma, Biotechnology, Pharmaceutical · 50 employees

Located in Redmond WA, founded in 2014, Systimmune Inc. is a bio-pharmaceutical company focused on the treatment of cancer through developing novel therapeutic bi-specific, and tri-specific antibodies, as well as antibody-drug conjugates (ADC's). Our objective is to create biologics that work through systematic intervention on the solid tumor micro-environment, to either directly attack the tumor

Funding history

  • Funding Round — $7.9M — Oct 2024
  • Funding Round — $7.2M — Jun 2024

Recent signals

  • Oct 18, 2024: Raised $7.9M
  • Jun 04, 2024: Raised $7.2M
  • May 23, 2024: SystImmune Appoints Dr. Jonathan Cheng as Chief Medical Officer
  • Apr 22, 2024: SystImmune Appoints Jie D'Elia, Ph.D., MBA, as Chief Executive Officer

See plans & pricing → Track SystImmune’s funding, hiring, and signals — with verified contacts — on Fundz.